Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort;Meta-analyse zu wirksamkeit und verträglichkeit der behandlung der leichten und mittelschweren depression mit Johanniskraut

Fortschritte der Neurologie Psychiatrie

Volumn 72, Issue 6, 2004, Pages 330-343

  Röder, Claudia ^a   Schaefer, Marion ^a   Leucht, S ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CALMIGEN; D 0496; FLUOXETINE; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; LOHYP 57; MAPROTILINE; PLACEBO; PSYCHOTONIN FORTE; PSYCHOTONIN M; SERTRALINE; STEI 300; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; WS 5572; ZE 117;

ADVERSE DRUG REACTION; ANXIETY DISORDER; CALCULATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG USE; GERANIACEAE; HAMILTON SCALE; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; MEDICAL LITERATURE; META ANALYSIS; PREVALENCE; PUBLICATION; QUALITY CONTROL; REVIEW;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; HYPERICUM; PHYTOTHERAPY; RESEARCH DESIGN;

EID: 3042642154     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812513     Document Type: Review

References (85)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshlem S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United states. Results from the National Comorbidity Survey. Archives of General Psychiatry 1994; 51: 8-19
2. Murray JB. Cardiac disorders and antidepressant medications. J Psychol 2000; 134: 162-168
3. Lennecke K. Depressive Patienten. DAZ 1998; 138: 45-56
4. Kim HL, Streltzer J, Goebert D. St. John's wort for depression: a meta-analysis of well-defined clinical trials. J Nerv Ment Dis 1999; 187: 532-538
5. Kasper S, Dienel A. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in midly to moderately depressed out-patients. A meta-analysis of data from 3 randomized, placebo-controlled trials. Psychopharmacology 2002; 164(3): 301-308
6. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258
7. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2000; CD000448
8. Whiskey E, Werneke U, Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16: 239-252
9. Kleijnen J, Kniepschild P, ter Riet G. Clinical trials of homeopathy. BMJ 1991; 302: 316-332
10. Ernst E. St John's Wort, an anti-depressant? A systematic, criteria-based review. Phytomedicine 1995; 2: 67-71
11. Hamilton M. Hamilton Depression Scale. In: ECDEU Assessment Manual for Psychopharmacology. Maryland: Rockville, 1976: 179-192
12. Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H et al. Consensus on the methodology of clinical trials of antidepressants, Zurich, March 1988; Report of the Consensus Committee. Pharmacopsychiatry 1989; 22: 3-7
13. DerSimonian RLN. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-188
14. Rosenthal R. The "file drawer" problem and tolerance for null results. Psychol Bull 1979; 86: 638-641
15. Ditzler K, Gessner B, Schatton WFH, Willems M. Clinical trial on Neuropas versus placebo in patients with mild to moderate depressive symptoms. A placebo-controlled, randomised double-blind study. Complementary Therapies in Medicine 1994; 2: 5-13
16. Hänsgen KD, Vesper J, Ploch M. Multizentrische Doppelblindstudie zur antidepressiven Wirksamkeit des Hypericum-Extraktes LI 160. Nervenheilkunde 1993; 12: 285-289
17. Hänsgen KD, Vesper J, Ploch M. Multi-center double-blind study examining the antidepressant effectiveness of Hypericum extract LI 160. J Geriatr Psychiatry Neurol 1994; 7: 15-18
18. Hänsgen KD, Vesper J. Antidepressive Wirksamkeit eines hochdosierten Hypericum-Extraktes. Münchener Medizinische Wochenschrift 1996; 3: 29-33
19. Holsboer-Trachsler E, Vanoni C. [Clinical efficacy and tolerance of the hypericum special extract LI 160 in depressive disorders - a drug monitoring study]. Schweiz Rundsch Med Prax 1999; 88: 1475-1480
20. Hübner WD, Arnoldt KH. Johanniskraut-Einjahresstudie. Offene multizentrische Therapiestudie mit Johanniskrautextrakt LI 160 bei Patienten mit depressiven Erkrankungen. Zeitschrift für Phytotherapie 2000; 21: 306-310
21. Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A. Effects of Hypericum extract LI 160 compared with Maprotiline on resting EEG and evoked potentials in 34 volunteers. J Geriatr Psychiatry Neurol 1994; 7: 44-46
22. Kalb R, Arnoldt KH, Klemann A. Langzeitbehandlung mit Johanniskraut-Extrakt LI160. Der Allgemeinarzt 1999; 21: 1726-1728
23. Kasper S. Treatment of seasonal affective disorder (SAD) with hypericum extract. Pharmacopsychiatry 1997; 30: 89-93
24. Kniebel R, Burchard JM. Zur Therapie depressiver Verstimmungen in der Praxis. Zeitschrift für Allgemeinmedizin 1988; 64: 689-696
25. Kugler J, Weidenhammer W, Schmidt A, Groll S. Therapie depressiver Zustände. Z Allg Med 1990; 66: 21-29
26. Lehrl S, Willemsen A, Papp R, Woelk H. Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unter der Therapie mit Johanniskraut-Extrakt. Nervenheilkunde 1993; 12: 281-284
27. Lenoir S, Degenring FH, Saller R. A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L. Phytomedicine 1999; 6: 141-146
28. Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol 1994; 7: 29-33
29. Montgomery SA, Hübner WDGH. Efficacy and tolerability of St. John's wort extract compared with placebo in patients with a mild to moderate depressive disorder. Phytomedicine 2000; 7: 107
30. Mueller BM. St. John's Wort for depressive disorders: results of an outpatient study with the Hypericum preparation HYP 811. Adv Ther 1998; 15: 109-116
31. Pleschl D, Angersbach P, Torman M. Zur Behandlung von Depressionen. Verbundstudie mit einem pflanzlichen Extrakt aus Johanniskraut. Therapiewoche 1989; 39: 2567-2571
32. Schulz H, Jobert M. Effects of hypericum extract on the sleep EEG in older volunteers. J Geriatr Psychiatry Neurol 1994; 7: 39-43
33. Staffeldt B, Kerb R, Brockmoller J, Ploch M, Roots I. Pharmakokinetik von Hypericin und Pseudohypericin nach oraler Einnahme des Johanniskrautextraktes LI 160 bei gesunden Probanden. Nervenheilkunde 1993; 12: 331-338
34. Steger W. Depressive Verstimmungen. Randomisierte Doppelblind-studie zum Wirksamkeitsvergleich einer pflanzlichen Wirkstoffkombination und eines synthetischen Antidepressivums. Z Allg Med 1985; 61: 914-918
35. Warnecke G. Beeinflussung klimakterischer Depressionen. Zeitschrift für Allgemeinmedizin 1986; 62: 1111-1113
36. Werth W. Psychotonin M versus Imipramin in der Chirurgie. Der Kassenarzt 1989; 15: 64-84
37. Winkel R, Koritsch HD, Piayda H, Trenckmann USt. John's wort extract LI 160 in depressive, alcohol-addicted patients. Phytomedicine 2000; 7: 19
38. Woelk H, Beneke M, Gebert I, Rappard F, Rechziegler H. Hypericum extract Ze 117: an open long-term study in patients with mild-moderate depression. Phytomedicine 2000; (suppl. 2): 109-115
39. Bjerkenstedt L, Edman GV, Alken RC, Mannel M. Hypericum extract LI 160 and fluoxetine in mild to moderate depression - a randomised, placebo-controlled multi-centre study in out-patients. submitted.
40. Bracher A. Johanniskraut 1 × täglich: Wirkung klinisch belegt. ÄP Neurologie Psychiatrie 2001; 4: 22-24
41. Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J et al. A double-blind, randomized trial of St. John's wort, fluoxetine, and placebo in Major Depressive Disorder. submitted.
42. Halama P. Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung. Nervenheilkunde 1991; 10: 253
43. Harrer G, Schmidt U, Kuhn U. "Alternative" Depressionsbehandlung mit einem Hypericum-Extrakt. TW Neurol Psychiatr 1991; 5: 710-716
44. Hoffmann J, Kühl ED. Therapie von depressiven Zuständen mit Hypericin. Z Allg Med 1979; 55: 776-782
45. Hubner WD, Lande S, Podzuweit H. Hypericum treatment of mild depressions with somatic symptoms. J Geriatr Psychiatry Neurol 1994; 7: 12-14
46. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder. A randomized controlled trial. JAMA 2002; 287: 1807-1814
47. Kalb R, Trautmann-Sponsel RD, Kieser M. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 2001; 34: 96-103
48. Laakmann G, Schule C, Baghai T, Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998; 31: 54-59
49. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's Wort Extract WS 5570 in major depression: A double-blind, placebo-controlled trial. Am J Psychiatry 2002; 159: 1361-1366
50. Osterheider M, Schmidtke A, Beckmann H. Behandlung depressiver Syndrome mit Hypericum (Johanniskraut) - Eine plazebokontrollierte Doppelblindstudie. Fortschr Neurol Psychiatr 1992; 60: 210-211
51. Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 1999; 319: 1534-1538
52. Quant J, Schmidt U, Schenk N. Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen. Der Allgemeinarzt 1993; 2: 97-102
53. Reh C, Laux P. Hypericum-Extrakt bei Depressionen - eine wirksame Alternative. Therapiewoche 1992; 42: 1576-1581
54. Schlich D, Braukmann F, Schenk N. Behandlung depressiver Zustandsbilder mit Hypericum. Psycho 1987; 13: 440-447
55. Schmidt U, Schenk N, Schwarz I, Vorberg G. Zur Therapie depressiver Verstimmungen. Psycho 1989; 15: 665-671
56. Schmidt U, Sommer H. Johanniskraut-Extrakt zur ambulanten Therapie der Depression. Fortschr Neurol Psychiatr 1993; 111: 339-342
57. Schrader E, Meier B, Brattstrom A. Hypericum treatment of mild-moderate depression in a placebo-controlled study. Hum Psychopharmacol 1998; 13: 163-169
58. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 2001; 285: 1978-1986
59. Sommer H, Harrer G. Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 1994; 7: 9-11
60. Volz HP, Eberhardt R, Grill G. Wirksamkeit und Verträglichkeit des Johanniskrautextraktes D-0496 bei leichten bis mittelschweren depresiven Episoden. Plazebokontrollierte Doppelblindstudie über 6 Wochen. Nervenheilkunde 2000; 19: 401-405
61. Witte VB, Harrer G, Kaptan T et al. Treatment of depressive symptoms with a high concentration hypericum preparation: A multicenter placebo-controlled double-blind study. Fortschr Med 1995; 113: 404-408
62. Behnke K, Jensen GS, Graubaum HJ, Gruenwald J. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Adv Ther 2002; 19: 43-52
63. Bergmann R, Nüßler J, Demling J. Behandlung leichter bis mittelschwerer Depressionen. TW Neurol Psychiatr 1993; 7: 235-240
64. Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clin Ther 2000; 22: 411-419
65. Gurp G van, Meterissian GB, Haiek LN, McCusker J, Bellavance F. St John's wort or sertraline? Randomized controlled trial in primary care. Can Fam Physician 2002; 48: 905-912
66. Harrer G, Sommer H. Therapie leichter u. mittelschwerer Depressionen mit Hypericum. Münch med Wschr 1993; 135: 305-309
67. Harrer G, Schmidt U, Kuhn U, Biller A. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine. Arzneimittelforschung 1999; 49: 289-296
68. Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 2000; 15: 61-68
69. Vorbach EU, Hubner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7: 19-23
70. Vorbach EU, Arnoldt KH, Hubner WD. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 1997; 30: 81-85
71. Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 1997; 30: 77-80
72. Woelk H. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. BMJ 2000; 321: 536-539
73. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
74. Rosenberg MS, Adams DC, Gurevitch J. MetaWin 2.0 - statistical software for meta-analysis. Sinauer associates, Funderland, Massachusetts, 2003
75. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ 1997; 315: 617-619
76. Rote Liste. 2002
77. Angst J, Merikangas K. The depressive spectrum: diagnostic classification and course. J Affect Disord 1997; 45: 31-40
78. Horwarth E, Johnson J, Klerman GL, Weissmann MM. Depressive symptoms as relative and attributable risk factors for first-onset major depression. Archives of General Psychiatry 1992; 49: 823
79. Klerman GL, Weissmann MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry 1992; 49: 831-834
80. Warner V, Weissmann MM, Fendrich M, Wickramaratne P, Moreau D. The course of major depression in the offspring of depressed patients: indecende, recurrence, and recovery. Arch Gen Psychiatry 1992; 49: 782-787
81. Wells KB, Burnam MA, Rogers W. Course of depression for adult outpatients: results from the medical outcomes study. Arch Gen Psychiatry 1992; 49: 788-794
82. Murck H. Die atypische Depression und verwandte Erkrankungen - Neurobiologische Grundlagen für ihre Behandlung mit Johanniskraut-Extrakt. WMW 2002; 15/16: 398-403
83. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997; 315: 640-645
84. "Bühler Brief". Schreiben des BfArM vom 07.09.1995. 1995
85. Note for Guidance on clinical investigation of medicinal products in the treatment of depression. CPMP/EWP/518/97 REV. 1. 2002